1. Home
  2. TVRD vs FNKO Comparison

TVRD vs FNKO Comparison

Compare TVRD & FNKO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVRD
  • FNKO
  • Stock Information
  • Founded
  • TVRD 2017
  • FNKO 2017
  • Country
  • TVRD United States
  • FNKO United States
  • Employees
  • TVRD N/A
  • FNKO N/A
  • Industry
  • TVRD Biotechnology: Pharmaceutical Preparations
  • FNKO Recreational Games/Products/Toys
  • Sector
  • TVRD Health Care
  • FNKO Consumer Discretionary
  • Exchange
  • TVRD Nasdaq
  • FNKO Nasdaq
  • Market Cap
  • TVRD 246.5M
  • FNKO 225.8M
  • IPO Year
  • TVRD N/A
  • FNKO 2017
  • Fundamental
  • Price
  • TVRD $26.91
  • FNKO $4.55
  • Analyst Decision
  • TVRD Strong Buy
  • FNKO Buy
  • Analyst Count
  • TVRD 4
  • FNKO 4
  • Target Price
  • TVRD $58.50
  • FNKO $9.88
  • AVG Volume (30 Days)
  • TVRD 92.7K
  • FNKO 1.1M
  • Earning Date
  • TVRD 08-21-2025
  • FNKO 08-07-2025
  • Dividend Yield
  • TVRD N/A
  • FNKO N/A
  • EPS Growth
  • TVRD N/A
  • FNKO N/A
  • EPS
  • TVRD N/A
  • FNKO N/A
  • Revenue
  • TVRD N/A
  • FNKO $1,024,890,000.00
  • Revenue This Year
  • TVRD N/A
  • FNKO N/A
  • Revenue Next Year
  • TVRD N/A
  • FNKO $9.22
  • P/E Ratio
  • TVRD N/A
  • FNKO N/A
  • Revenue Growth
  • TVRD N/A
  • FNKO N/A
  • 52 Week Low
  • TVRD $8.13
  • FNKO $3.50
  • 52 Week High
  • TVRD $34.31
  • FNKO $14.65
  • Technical
  • Relative Strength Index (RSI)
  • TVRD N/A
  • FNKO 46.33
  • Support Level
  • TVRD N/A
  • FNKO $4.21
  • Resistance Level
  • TVRD N/A
  • FNKO $4.72
  • Average True Range (ATR)
  • TVRD 0.00
  • FNKO 0.28
  • MACD
  • TVRD 0.00
  • FNKO -0.06
  • Stochastic Oscillator
  • TVRD 0.00
  • FNKO 35.42

About TVRD Tvardi Therapeutics Inc. Common Stock

Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.

About FNKO Funko Inc.

Funko Inc is an us-based pop culture consumer products company. It creates whimsical, fun, and different products that enable the customer to express their affinity for their favorite through the movie, TV show, video game, musician, or sports team. The company's current products are principally figures, fashion accessories, apparel, plush products, accessories, homewares, and NFTs. The company sells its products through a diverse network of retail customers across multiple retail channels, including specialty retailers, mass-market retailers, and e-commerce sites. The company generates the majority of its revenue from the core collectibles products.

Share on Social Networks: